CHU de Nantes Hopital Hotel Dieu

Nantes 44093

0 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Depressive Disorder, Major, HIV Infections, Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age — Stopped early
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed